Related references
Note: Only part of the references are listed.Deregulated expression of VHL mRNA variants in papillary thyroid cancer
Enke Baldini et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium
Hisashi Hasegawa et al.
BMC CANCER (2017)
Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR
Yazeed A. Al-Sheikh et al.
ONCOLOGY LETTERS (2016)
Expression and prognostic value of miR-92a in patients with gastric cancer
Chuanli Ren et al.
TUMOR BIOLOGY (2016)
MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3β and activating Wnt signaling in bladder cancer cells
Haifeng Wang et al.
TUMOR BIOLOGY (2016)
Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis
Laura Smith et al.
PLOS ONE (2015)
VHL, the story of a tumour suppressor gene
Lucy Gossage et al.
NATURE REVIEWS CANCER (2015)
An update on molecular biology of thyroid cancers
Ozgur Omur et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Low VHL mRNA Expression is Associated with More Aggressive Tumor Features of Papillary Thyroid Carcinoma
Boban Stanojevic et al.
PLOS ONE (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma
Weiqi Tan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Emerging molecular markers for the prognosis of differentiated thyroid cancer patients
Enke Baldini et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
miRNAs: Their discovery, biogenesis and mechanism of action
N. Tetreault et al.
CLINICAL BIOCHEMISTRY (2013)
The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma
Tomoo Jikuzono et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Expression and significance of PTEN and miR-92 in hepatocellular carcinoma
Bin Zhao et al.
MOLECULAR MEDICINE REPORTS (2013)
MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells
Yu Yu et al.
ONCOLOGY LETTERS (2013)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Pacini et al.
ANNALS OF ONCOLOGY (2012)
Reduced Expression of von Hippel-Lindau Protein Correlates with Decreased Apoptosis and High Chondrosarcoma Grade
Changbao Chen et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2011)
Papillary thyroid carcinoma: an update
Virginia A. LiVolsi
MODERN PATHOLOGY (2011)
Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma
Vladimir A. Valera et al.
JOURNAL OF CANCER (2011)
Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
Hakeemah Al-Nakhle et al.
CANCER RESEARCH (2010)
Thyroid Carcinoma
R. Michael Tuttle et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials
Esmerina Tili et al.
NUCLEIC ACIDS RESEARCH (2010)
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K. Ghosh et al.
BLOOD (2009)
The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms
Isabella Manni et al.
FASEB JOURNAL (2009)
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells
Shu Takakura et al.
CANCER SCIENCE (2008)
Targeted deletion reveals essential and overlapping functions of the miR-17∼92 family of miRNA clusters
Andrea Ventura et al.
CELL (2008)
BRAF mutation in papillary thyroid cancer:: Pathogenic role, molecular bases, and clinical implications
Mingzhao Xing
ENDOCRINE REVIEWS (2007)
microRNAs exhibit high frequency genomic alterations in human cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis
R. H. Giles et al.
ONCOGENE (2006)
Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma
Christian A. Koch et al.
BMC CANCER (2006)
Survival and death causes in differentiated thyroid carcinoma
CFA Eustatia-Rutten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
M Schlumberger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors
JL Hunt et al.
SURGERY (2003)
Expression of the von Hippel-Lindau tumor suppressor gene in nonneoplastic and neoplastic lesions of the thyroid
R Hinze et al.
ENDOCRINE PATHOLOGY (2000)
Share Paper
